---
$id: https://graph.org.ai/products/commodity/51152003
$type: Product
source: UNSPSC
code: "51152003"
title: "Rocuronium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rocuronium

**UNSPSC Code**: 51152003
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic antagonist with the molecular formula C32H53N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WRE554RFEZ. European Medicines Agency schedules rocuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04260MIG. ROCURONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ROCURONIUM remains the US FDA Preferred Term for this commodity. Rocuronium bears US NLM identifiers UMLS ID C0209337 and NCI Concept Code C80999. SMILES: O(C1C2(C(C3C(C4(C(CC3)CC(O)C(N3CCOCC3)C4)C)CC2)CC1[N]1(CCCC1)CC=C)C)C(=O)C.

